47 results on '"Kerbel, Robert S."'
Search Results
2. The potential clinical promise of ‘multimodality’ metronomic chemotherapy revealed by preclinical studies of metastatic disease
3. Targeting Hypoxia-Inducible Factors for Antiangiogenic Cancer Therapy
4. A CD276 Antibody Guided Missile with One Warhead and Two Targets: The Tumor and Its Vasculature
5. Metronomic Chemotherapy: Possible Clinical Application in Advanced Hepatocellular Carcinoma
6. Preclinical recapitulation of antiangiogenic drug clinical efficacies using models of early or late stage breast cancer metastatis
7. Controlling angiogenesis in breast cancer: A systematic review of anti-angiogenic trials
8. Reappraising antiangiogenic therapy for breast cancer
9. miR-30b/30d Regulation of GalNAc Transferases Enhances Invasion and Immunosuppression during Metastasis
10. Preclinical approaches to study the biology and treatment of brain metastases
11. Metronomic S-1 Chemotherapy and Vandetanib: An Efficacious and Nontoxic Treatment for Hepatocellular Carcinoma
12. Tumors That Acquire Resistance to Low-Dose Metronomic Cyclophosphamide Retain Sensitivity to Maximum Tolerated Dose Cyclophosphamide
13. Development of a Resistance-like Phenotype to Sorafenib by Human Hepatocellular Carcinoma Cells Is Reversible and Can Be Delayed by Metronomic UFT Chemotherapy
14. Impact of Metronomic UFT/Cyclophosphamide Chemotherapy and Antiangiogenic Drug Assessed in a New Preclinical Model of Locally Advanced Orthotopic Hepatocellular Carcinoma
15. Issues regarding improving the impact of antiangiogenic drugs for the treatment of breast cancer
16. The multiple personality disorder phenotype(s) of circulating endothelial cells in cancer
17. Accelerated Metastasis after Short-Term Treatment with a Potent Inhibitor of Tumor Angiogenesis
18. Tumor-Associated Fibroblasts as “Trojan Horse” Mediators of Resistance to Anti-VEGF Therapy
19. Rapid Chemotherapy-Induced Acute Endothelial Progenitor Cell Mobilization: Implications for Antiangiogenic Drugs as Chemosensitizing Agents
20. Phosphorylated Epidermal Growth Factor Receptor on Tumor-Associated Endothelial Cells Is a Primary Target for Therapy with Tyrosine Kinase Inhibitors
21. Judah Folkman 1933–2008
22. Molecular and cellular biomarkers for angiogenesis in clinical oncology
23. Detecting Vascular Changes in Tumour Xenografts Using Micro-Ultrasound and Micro-CT Following Treatment with VEGFR-2 Blocking Antibodies
24. Anti-angiogenic treatment of breast cancer using metronomic low-dose chemotherapy
25. ras Oncogene Triggers Up-regulation of cIAP2 and XIAP in Intestinal Epithelial Cells
26. Therapeutic implications of intrinsic or induced angiogenic growth factor redundancy in tumors revealed
27. A Cyclosporine-Sensitive Psoriasis-Like Disease Produced in Tie2 Transgenic Mice
28. Careful Decoy Receptor Titering is Required to Inhibit Tumor Angiogenesis While Avoiding Adversely Altering VEGF Bioavailability
29. Genetic heterogeneity of the vasculogenic phenotype parallels angiogenesis
30. Acquired resistance to EGFR inhibitors: mechanisms and prevention strategies
31. Antiangiogenic drugs and current strategies for the treatment of lung cancer
32. Selective anti-endothelial effects of protracted low-dose BAL-9504, a novel geranylgeranyl-transferase inhibitor
33. Dok-R Binds c-Abl and Regulates Abl Kinase Activity and Mediates Cytoskeletal Reorganization
34. High-frequency 3-D color-flow imaging of the microcirculation
35. Multicellular gastric cancer spheroids recapitulate growth pattern and differentiation phenotype of human gastric carcinomas
36. Heterogeneous Vascular Dependence of Tumor Cell Populations
37. Oncogenes and Angiogenesis: Signaling Three-Dimensional Tumor Growth
38. High-frequency color flow imaging of the microcirculation
39. Marked Induction of the IAP Family Antiapoptotic Proteins Survivin and XIAP by VEGF in Vascular Endothelial Cells
40. Functional Dissociation of Anoikis-like Cell Death and Activity of Stress Activated Protein Kinase
41. Collateral Expression of Proangiogenic and Tumorigenic Properties in Intestinal Epithelial Cell Variants Selected for Resistance to Anoikis
42. Downregulation of the pro-apoptotic protein Bak is required for the ras-induced transformation of intestinal epithelial cells
43. Protein Expression of the Cell-Cycle Inhibitor p27Kip1 in Malignant Melanoma
44. Constitutive Production of 92-kDa Gelatinase B Can Be Suppressed by Alterations in Cell Shape
45. Resistance of Malignant Trophoblast Cells to both the Anti-proliferative and Anti-invasive Effects of Transforming Growth Factor-β
46. Establishment and Characterization of First Trimester Human Trophoblast Cells with Extended Lifespan
47. 5-Azacytidine induction of thymidine kinase in a spontaneously enzyme-deficient murine tumor line
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.